Founded on Breakthrough Science
Elios’ personalized therapeutic cancer vaccine technology was discovered and developed by Dr. Thomas Wagner, an internationally-renowned, award-winning pioneer of biomedical research and molecular biology. Dr. Wagner’s personal and scientific journey led him to develop and patent transgenic technology which has revolutionized the way we research cancer today. He was also among the first to develop methods of cell-based therapies, and for the past two decades, Dr. Wagner’s research has focused exclusively on the application of modern molecular and cellular biology to the development of new therapies for the treatment of cancer.
Dr. Wagner has served as a scientific advisor to the World Health Organization, to the U.S. Congress, and to the White House under former President Ronald Reagan. Based on over 50 years of Dr. Wagner’s breakthrough scientific research and discovery, the cutting-edge technology behind the TLPO and TLPLDC vaccines may lead to further therapeutic innovations for currently intractable diseases.
Dr. Thomas E. Wagner, Ph.D. Renowned cancer researcher and creator of the TLPO and TLPLDC personalized therapeutic cancer vaccines